Barr Paul

Burkitt Lymphoma is a rapidly progressive lymphoid malignancy requiring a prompt diagnosis and institution of therapy. Often, therapy needs to be instituted prior to the results of molecular studies which typically confirm the diagnosis. A goal of initiating therapy within 48 hours of presentation has been proposed as optimal treatment for Burkitt lymphoma. Therefore, a…